Cell and Gene Manufacturing and Logistics

  1. Transfer Of Fed-Batch To Semi-Perfusion Process 4/14/2025

    Continuous processes enhance product quality, yield, and cost savings. Explore transitioning a fed-batch process to perfusion using a small batch bioreactor system to optimize cell culture conditions and comparing performances.

  2. Rapid A BioSMB Biolayer Interferometry Technology 4/14/2025

    Monoclonal antibodies are crucial for treating severe diseases. Explore dynamic loading in continuous multi-column chromatography and the growing market due to high specificity and fewer side effects.

  3. How To Intensify Upstream Process Development 4/14/2025

    Discover systems that are essential for accelerating cell culture process development, as well as learn about their intensification modes and real-world benefits.

  4. Improve Productivity And Reduce Risk With Biostat® RM 4/14/2025

    Discover how a company overcame cell generation challenges by using a system that achieves a seed ratio of 1:120 and saves four days in seed preparation time.

  5. An Unrivaled Modular Seed Train For Process Intensification 4/14/2025

    Listen to experts as they discover a modular, perfusion-enabled seed train system and learn about the time benefits, cost benefits, and scalable process development for various production needs.

  6. Cost Effective 2D Rocking Motion Bioreactors For Perfusion Processes 4/14/2025

    Discover how modern technology platforms, like 2D rocking motion bioreactors, intensify bio-manufacturing processes to drive seed ratios, reduce costs, and shorten production times in biopharma.

  7. VirusGEN® Transfection Complex Stabilizer 4/14/2025

    Scale AAV production with peace of mind. Extend transfection complex formation time by up to 3 hours, reduce complex volume by >50%, and maintain high titers and full capsids.

  8. From Tissue Donation To Distribution: Understanding EU Regulatory Requirements In Cell Therapy Clinical Trials 4/14/2025

    Understanding how the European Union's Directive 2004/23/EC interacts with GMP — and where its jurisdiction begins and ends — is essential for successful clinical trial planning, compliance, and execution.

  9. The 3 Most Overlooked Costs In Monoclonal Antibody Production 4/11/2025

    Explore the dynamic field of therapeutic biotechnology, examining the intricacies of mAb manufacturing and uncovering the often-overlooked factors driving high production costs.

  10. Forget About Isolators: Switching From Manual Vial To Automated Bag Filling 4/11/2025

    Discover how transitioning from manual vial filling to single-use bag systems can reduce contamination risk, improve accuracy, and enhance GMP compliance in biopharmaceutical manufacturing.